Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol

Transplant International

Volumn 28, Issue 12, 2015, Pages 1383-1391

  Bhat, Mamatha ^a   Hathcock, Matthew ^a   Kremers, Walter K ^a   Darwish Murad, Sarwa ^a   Schmit, Grant ^a   Martenson, James ^a   Alberts, Steven ^a   Rosen, Charles B ^a   Gores, Gregory J ^a   Heimbach, Julie ^a  

^a MAYO CLINIC   (United States)

Author keywords

chemotherapy; Cholangiocarcinoma; liver transplantation; portal vein encasement; radiotherapy

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; FLUOROURACIL; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT CARCINOMA; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; DRUG RESPONSE; DRUG TOLERABILITY; EXPLANT; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MELD SCORE; PERIHILAR CHOLANGIOCARCINOMA; PORTAL VEIN ENCASEMENT; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; VEIN DISEASE; ADJUVANT CHEMORADIOTHERAPY; BILE DUCT NEOPLASMS; BIOLOGICAL MODEL; CLINICAL PROTOCOL; KAPLAN MEIER METHOD; KLATSKIN TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PATHOLOGY; PORTAL VEIN; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; BILE DUCT NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; CLINICAL PROTOCOLS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KLATSKIN TUMOR; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84960380877     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12640     Document Type: Article

References (20)

1. Gores GJ,. Cholangiocarcinoma: current concepts and insights. Hepatology 2003; 37: 961.
2. Rea DJ, Heimbach JK, Rosen CB, et al,. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451; discussion 8-61.
3. Su CH, Tsay SH, Wu CC, et al,. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223: 384.
4. Rea DJ, Munoz-Juarez M, Farnell MB, et al,. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 2004; 139: 514; discussion 23-5.
5. Jarnagin WR, Fong Y, DeMatteo RP, et al,. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507; discussion 17-9.
6. DeOliveira ML, Cunningham SC, Cameron JL, et al,. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755.
7. Heimbach JK, Gores GJ, Haddock MG, et al,. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24: 201.
8. Heimbach JK, Gores GJ, Nagorney DM, Rosen CB,. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery 2006; 140: 331.
9. De Vreede I, Steers JL, Burch PA, et al,. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309.
10. Darwish Murad S, Kim WR, Harnois DM, et al,. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143: 88.e3; quiz e14.
11. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ,. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 2009; 18: 325.
12. Heimbach JK, Gores GJ, Haddock MG, et al,. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82: 1703.
13. Darwish Murad S, Kim WR, Therneau T, et al,. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology 2012; 56: 972-81.
14. Dubben HH, Thames HD, Beck-Bornholdt HP,. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 1998; 47: 167-74.
15. Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D,. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002; 7: 492-508.
16. Macdonald G, Hurman DC,. Influence of anaemia in patients with head and neck cancer receiving adjuvant postoperative radiotherapy in the Grampian region. Clin Oncol (R Coll Radiol) 2004; 16: 63-70.
17. Zlobec I, Steele R, Nigam N, Compton CC,. A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods. Clin Cancer Res 2005; 11: 5440-3.
18. Huang PY, Wang CT, Cao KJ, et al,. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial. Eur J Cancer 2013; 49: 1923-31.
19. Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ,. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg 2012; 215: 31; discussion 8-40.
20. Harrison L, Blackwell K,. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 2004; 9 (Suppl 5): 31-40.